-
A federal judge has overturned a bankruptcy settlement worth more than $4 billion that granted immunity from opioid lawsuits to members of the family who owns the company that makes OxyContin.
-
With a federal judge poised to approve Purdue Pharma's controversial Chapter 11 plan, the company is working behind the scenes to preempt a legal challenge by the Justice Department.
-
Massachusetts and New York are among the states agreeing to end the fight to halt a controversial Purdue Pharma bankruptcy plan. The deal shelters members of the Sackler family from opioid lawsuits.
-
If the bankruptcy plan is approved, Florida could get up to $280 million to $400 million over a 10-year period.
-
Under a bankruptcy plan filed late Monday, the OxyContin maker would pay $500 million up front, promising billions in future payments. Twenty-four states rejected the proposal.
-
Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of OxyContin, which helped fuel the nation's opioid epidemic.
-
In the 15 years since she lost her son to a single OxyContin pill, Barbara Van Rooyan has had but one up-close look at the people representing the company…
-
OxyContin maker Purdue Pharma reached a tentative deal Wednesday with about half the states and thousands of local governments over its role in the...
-
State attorneys general and lawyers representing local governments said Tuesday they are in active settlement talks with Purdue Pharma, the maker of the…
-
Florida's largest health insurer has seen a 45 percent drop in opioid prescriptions since it stopped paying for OxyContin. It has been almost a year...